ACVRL1 and colorectal carcinoma: Taken together, these findings suggest that the overexpression of ACVRL1 contributes to the resistance to mTKIs, whereas the inhibition of ACVRL1 significantly increases the sensitivity of CRC cells to mTKIs both in vitro and vivo.